Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly

scientific article published on February 1, 2003

Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF03345139
P953full work available at URLhttp://link.springer.com/article/10.1007/BF03345139/fulltext.html
http://link.springer.com/content/pdf/10.1007/BF03345139
http://link.springer.com/content/pdf/10.1007/BF03345139.pdf
P698PubMed publication ID12739738

P50authorAnnamaria ColaoQ64495559
Paola RazzoreQ99552546
P2093author name stringE. Ghigo
F. Camanni
M. Gasperi
E. Martino
M. Giusti
E. Ciccarelli
S. Grottoli
D. Gaia
V. Gasco
P2860cites workThe Journal of Clinical Endocrinology and MetabolismQ3186902
Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than womenQ30466617
Investigation protocol: acromegaly and its investigationQ33704125
Determinants of circulating insulin-like growth factor-I.Q33708548
Criteria for cure of acromegaly: a consensus statementQ33848161
Nutritional regulation of the insulin-like growth factorsQ34339433
Somatotrope responsiveness to Hexarelin, a synthetic hexapeptide, is refractory to the inhibitory effect of glucose in obesityQ38350774
Current treatment guidelines for acromegalyQ40846028
Human growth hormone and human agingQ40906146
Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegalyQ40928588
Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.Q41656044
In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucoseQ42512966
Increasing growth with raised circulating somatomedin but normal immunoassayable growth hormoneQ44514242
Acromegaly with normal fasting growth hormone concentrations but abnormal growth hormone regulationQ44592641
Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assayQ45088930
Evaluation of Acromegaly by Radioimmunoassay of Somatomedin-CQ46894311
Growth-hormone and prolactin excessQ48785419
Glucose suppression of serum growth hormone in the diagnosis of acromegaly.Q51689262
Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults.Q55063316
Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegalyQ67273639
Responses of growth hormone and cortisol to intravenous glucose loading test in patients with anorexia nervosaQ68176647
Characterization of serum growth hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of serum GHQ69400476
Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretionQ69919209
Paradoxical elevation of growth hormone in active chronic hepatitisQ70122496
The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegalyQ70232094
Paradoxical release of growth hormone during oral glucose tolerance test in patients with abnormal glucose toleranceQ70242739
Growth hormone pulsatility in active and cured acromegalic subjectsQ70809158
New approach to the diagnosis of growth hormone deficiency in adultsQ71046146
Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapyQ72106085
A comparison of different methods for diagnosing acromegalyQ73529922
Evaluation of disease activity by IGF-I and IGF binding protein-3 (IGFBP3) in acromegaly patients distributed according to a clinical scoreQ74631141
Twenty-four hour profile of blood pressure in patients with acromegaly. Correlation with demographic, clinical and hormonal featuresQ74631149
Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegalyQ77549282
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectendocrinologyQ162606
P304page(s)123-127
P577publication date2003-02-01
P1433published inJournal of Endocrinological InvestigationQ15766847
P1476titleThree-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly
P478volume26

Reverse relations

cites work (P2860)
Q89724347Acromegaly in the elderly patients
Q44435847Acromegaly: Are new tests needed?
Q42473658Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up
Q51493161Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
Q45912383Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience.
Q39123579Biochemical investigations in diagnosis and follow up of acromegaly
Q42457597Clinical aspects and therapeutic outcome in thyrotropin-secreting pituitary adenomas: a single center experience
Q38131055Diagnosis of acromegaly: state of the art.
Q37140813Dynamic tests for the diagnosis and assessment of treatment efficacy in acromegaly
Q46665459Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients
Q83351941Effects of arginine treatment on nutrition, growth and urea cycle function in seven Japanese boys with late-onset ornithine transcarbamylase deficiency
Q33739766Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects
Q87888644Safety and specificity of the growth hormone suppression test in patients with diabetes
Q42654837The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: Mutational hot-spot or founder effect?

Search more.